Webinar: CER Collaborative: Tools You Can Use

Collaborative members hosted a webinar explaining how to use the tools they developed to create greater uniformity and transparency when evaluating evidence for coverage and health care decision-making. Leading researchers taught attendees about how these tools can help to ensure research studies are credible and relevant for decision-makers.

Topics included:

  • Compilations of good outcomes research practices for individual studies (e.g., prospective and retrospective observational studies, modeling approaches, indirect treatment comparisons);
  • Academy of Managed Care Pharmacy’s perspective on how the CER Collaborative’s resources can benefit formulary decision-makers;
  • New Comparative Effectiveness Research Continuing Education Certificate Program; and
  • NPC’s perspective on how the tools can assist the pharmaceutical industry.

Speakers:

  • Brian Sweet, Executive Director, U.S. Payer & Real World Evidence, AstraZeneca (moderator)
  • Marc Berger, Vice President, Real World Data And Analytics, Pfizer
  • Dan Allen, clinical pharmacist consultant, OmedaRx 
  • Bernadette Eichelberger, Director, Pharmacy Affairs, AMCP
  • Jennifer Graff, director, comparative effectiveness research, NPC
Publish Date: 
Thursday, April 10, 2014